COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,492 Articles (22,862 medRxiv, 8,630 bioRxiv)

Most recent first Previous |  Page 1543: Articles 15421-15430  | Next

SARS-CoV-2 Vaccine-Induced Antibody Response and Reinfection in Persons with Past Natural Infection
Chauhan, N., Chahar, A. S., Singh, P., Bhavesh, N. S., Tandon, R., Chaturvedi, R.
10.1101/2021.05.18.21257259 — Posted: 2021-05-18
Phylogenomics and population genomics of SARS-CoV-2 in Mexico reveals variants of interest (VOI) and a mutation in the Nucleocapsid protein associated with symptomatic versus asymptomatic carriers
Barona-Gomez, F., Delaye, L., Diaz-Valenzuela, E., Plisson, F., Cruz-Perez, A., Diaz-Sanchez, M., Garcia-Sepulveda, C. A., Sanchez-Flores, A., Perez-Abreu, R., Valencia-Valdespino, F. J., Vega-Magana, A. N., Munoz-Valle, J. F., Garcia-Gonzalez, O. P., Bernal-Silva, S., Comas-Garcia, A., Cibrian Jaramillo, A.
10.1101/2021.05.18.21256128 — Posted: 2021-05-18
Implications Derived from S-Protein Variants of SARS-CoV-2 from Six Continents
Hassan, S. S., Lundstrom, K., Pal Choudhury, P., Palu, G., Uhal, B., Kandimalla, R., Seyran, M., Lal, A., Sherchan, S. P., Azad, G. K., Aljabali, A. A. A., Brufsky, A., Serrano-Aroca, A., Adadi, P., Abd El-Aziz, T. M., Redwan, E. M., Takayama, K., Barh, D., Rezaei, N., Tambuwala, M., Uversky, V. N.
10.1101/2021.05.18.444675 — Posted: 2021-05-18
An intranasal ASO therapeutic targeting SARS-CoV-2
Zhu, C., Lee, J. Y., Woo, J. Z., Xu, L., Nguyenla, X., Yamashiro, L. H., Ji, F., Biering, S. B., Dis, E. V., Gonzalez, F., Fox, D., Rustagi, A., Pinsky, B. A., Blish, C. A., Chiu, C., Harris, E., Sadreyev, R. I., Stanley, S., Kauppinen, S., Rouskin, S., Näär, A. M.
10.1101/2021.05.17.444397 — Posted: 2021-05-18
Effects of common mutations in the SARS-CoV-2 Spike RBD domain and its ligand the human ACE2 receptor on binding affinity and kinetics
Barton, M. I., MacGowan, S., Kutuzov, M. A., Dushek, O., Barton, G. J., van der Merwe, P. A.
10.1101/2021.05.18.444646 — Posted: 2021-05-18
SARS-like coronaviruses in horseshoe bats (Rhinolophus spp.) in Russia, 2020.
Alkhovsky, S. V., Lenshin, S. V., Romashin, A. V., Vishnevskaya, T. V., Vyshemirsky, O. I., Bulycheva, Y. I., Lvov, D. K., Gitelman, A. K.
10.1101/2021.05.17.444362 — Posted: 2021-05-18
Single-dose immunisation with a multimerised SARS-CoV-2 receptor binding domain (RBD) induces an enhanced and protective response in mice
Salzer, R., Clark, J. J., Vaysburd, M., Chang, V. T., Albecka-Moreau, A., Kiss, L., Sharma, P., Gonzalez Llamazares, A., Kipar, A., Hiscox, J. A., Owen, A., Aricescu, A. R., Stewart, J. P., James, L. C., Lowe, J.
10.1101/2021.05.18.444622 — Posted: 2021-05-18
In Silico Molecular-Based Rationale for SARS-CoV-2 Spike Circulating Mutations Able to Escape Bamlanivimab and Etesevimab Monoclonal Antibodies
Laurini, E., Marson, D., Aulic, S., Fermeglia, A., PRICL, S.
10.1101/2021.05.18.444605 — Posted: 2021-05-18
Effect of COVID-19 on inequalities in premature mortality in England: an analysis of excess mortality by deprivation and ethnicity
Barnard, S., Fryers, P., Fitzpatrick, J., Fox, S., Baker, A., Burton, P., Newton, J., Doyle, Y., Goldblatt, P.
10.1101/2021.05.18.21256717 — Posted: 2021-05-18
Early Anakinra Treatment for COVID-19 Guided by Urokinase Plasminogen Receptor
Kyriazopoulou, E., Poulakou, G., Milionis, H., Metallidis, S., Adamis, G., Tsiakos, K., Fragkou, A., Rapti, A., Danoulari, C., Fantoni, M., Kalomenidis, I., Chrysos, G., Angheben, A., Kainis, I., Alexiou, Z., Castelli, F., Serino, F. S., Bakakos, P., Nicastri, E., Tzavara, V., Kostis, E., Dagna, L., Koufargyris, P., Dimakou, K., Tzatzagou, G., Chini, M., Bassetti, M., Katrini, K., Kotsis, V., Tsoukalas, G., Selmi, C., Bliziotis, I., Samarkos, M., Doumas, M., Ktena, S., Masgala, A., Papanikolaou, I., Argyraki, A., Cardellino, C. S., Katsigianni, E.-I., Giannitsioti, E., Cingolani, A., Akinosogl
10.1101/2021.05.16.21257283 — Posted: 2021-05-18

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).